Ten year audit of secondary prevention in coronary bypass patients

BMJ. 2000 Jul 1;321(7252):22-3. doi: 10.1136/bmj.321.7252.22.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticholesteremic Agents / therapeutic use
  • Aspirin / therapeutic use
  • Blood Pressure / physiology
  • Cholesterol / blood
  • Coronary Artery Bypass*
  • Humans
  • Medical Audit
  • Platelet Aggregation Inhibitors / therapeutic use
  • Postoperative Complications / prevention & control*
  • Risk Factors
  • Simvastatin / therapeutic use

Substances

  • Anticholesteremic Agents
  • Platelet Aggregation Inhibitors
  • Cholesterol
  • Simvastatin
  • Aspirin